6533b874fe1ef96bd12d62dd
RESEARCH PRODUCT
Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes
Javed ButlerJulio NúñezMilton PackerRudolf A. De BoerFaiez ZannadDomingo A. Pascual-figalSalva R. YuristaAntoni Bayes-genisEvelyn Santiago-vacasAntonio LaxOriol Iborra-egeaStephane HeymansJosep Lupónsubject
0301 basic medicinelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyCardiac & Cardiovascular Systemsempagliflozinheart failure030204 cardiovascular system & hematologySGLT2i sodium-glucose co-transporter 2 inhibitorHF heart failurePRECLINICAL RESEARCH03 medical and health sciences0302 clinical medicineDM diabetes mellitusDiabetes mellitusInternal medicinemedicineEmpagliflozinMI-HF post-infarct heart failureGlycemicScience & TechnologyEjection fractionbusiness.industryNHE sodium-hydrogen exchangerANN artificial neural networkmedicine.diseaseHFrEF HF with reduced ejection fractionBlockadeXIAPmachine learning030104 developmental biologyMechanism of actionlcsh:RC666-701Heart failureCardiovascular System & CardiologyCardiologyRNAseq RNA sequencingempagtiflozinmedicine.symptomCardiology and Cardiovascular MedicinebusinessLife Sciences & Biomedicinedescription
Visual Abstract
year | journal | country | edition | language |
---|---|---|---|---|
2019-11-01 | JACC: Basic to Translational Science |